Does TIRBANIBULIN Cause Application site erythema? 31 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Application site erythema have been filed in association with TIRBANIBULIN (Klisyri). This represents 15.7% of all adverse event reports for TIRBANIBULIN.
31
Reports of Application site erythema with TIRBANIBULIN
15.7%
of all TIRBANIBULIN reports
0
Deaths
0
Hospitalizations
How Dangerous Is Application site erythema From TIRBANIBULIN?
Of the 31 reports.
Is Application site erythema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TIRBANIBULIN. However, 31 reports have been filed with the FAERS database.
What Other Side Effects Does TIRBANIBULIN Cause?
Drug ineffective (44)
Drug intolerance (20)
Erythema (18)
Adverse drug reaction (17)
Application site exfoliation (17)
Application site vesicles (14)
Application site pain (12)
Off label use (11)
Application site dryness (10)
Application site pruritus (9)
What Other Drugs Cause Application site erythema?
NICOTINE (2,004)
SUMATRIPTAN (1,875)
INGENOL MEBUTATE (1,373)
BUPRENORPHINE (1,273)
ESTRADIOL (1,117)
MINOXIDIL (1,061)
METHYLPHENIDATE (543)
ESTRADIOL\NORETHINDRONE (533)
FENTANYL (501)
OXYTROL FOR WOMEN (422)
Which TIRBANIBULIN Alternatives Have Lower Application site erythema Risk?
TIRBANIBULIN vs TIROFIBAN
TIRBANIBULIN vs TIRZEPATIDE
TIRBANIBULIN vs TISAGENLECLEUCEL
TIRBANIBULIN vs TISLELIZUMAB
TIRBANIBULIN vs TISOTUMAB VEDOTIN